Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 75/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

50.0%

-36.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

50% success

Data Visualizations

Phase Distribution

11Total
Not Applicable (8)
P 1 (2)
P 2 (1)

Trial Status

Enrolling By Invitation5
Recruiting5
Not Yet Recruiting4
Terminated1
Completed1
Suspended1

Trial Success Rate

50.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT07723287Suspended

Risk Factors for Drug-Resistant Epilepsy in Children

NCT07716930Enrolling By InvitationPrimary

Retinal OCT Changes and Biomarkers in Drug-Resistant Epilepsy

NCT07110454Recruiting

Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up

NCT07704606Not Yet Recruiting

Metabolites in Blood and Breath in Metabolic Conditions

NCT07110337Not ApplicableRecruiting

Diagnosing Epilepsy To EffeCT Change

NCT07680842Not ApplicableRecruiting

Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

NCT07378397Enrolling By InvitationPrimary

OPM MEG in Pre-surgical Mapping for Patients With Epilepsy

NCT07353918Not ApplicableEnrolling By InvitationPrimary

Low-Intensity Focused Ultrasound Neuromodulation for Epilepsy

NCT07316972Not ApplicableNot Yet RecruitingPrimary

CEST-based Biomarkers to Delineate the Epileptogenic Zone

NCT07249190Phase 1Not Yet RecruitingPrimary

A Study to Evaluate the Safety and Effectiveness of Magnetic Resonance-Guided Ultrasound Ablation of the Anterior Nucleus of Thalamus for the Treatment of Drug-resistant Epilepsy.

NCT07220161Not ApplicableActive Not RecruitingPrimary

Trigeminal Nerve Stimulation of the Treatment of Epilepsy

NCT06952764Not ApplicableEnrolling By InvitationPrimary

Epilepsy Cycles Longitudinal Monitoring to Inform Personalized Seizure-risk Estimation (ECLIPSE)

NCT06863350Not ApplicableRecruitingPrimary

Percutaneous Repair for Drug - Resistant Epilepsy by Intervention of Closing the Patent Foramen Ovale(PREDICT-PFO Trial)

NCT06832020CompletedPrimary

Determinants of Adaptive Behavior Through the Vineland Scale in Pediatric Patients with Severe and Drug-resistant Epilepsy

NCT06762743Phase 1Enrolling By InvitationPrimary

Bioequivalence Study of Two Brivaracetam Oral Solutions in Healthy Adults Under Fasting and High-Fat Meal Conditions

NCT05845255Recruiting

Evaluation of the Epilepsy-related Quality of Life, Seizure-related Accidents and Validation of the Mjn-SERAS Solution in the Normalised Patient Environment with Real-World Data

NCT06593444Not ApplicableNot Yet RecruitingPrimary

Thalamic Ventral Intermediate Electrical Stimulation for Refractory Familial Cortical Myoclonus with Epilepsy

NCT01769092Phase 2TerminatedPrimary

Clinical Trial of the Effects of DHA in the Treatment of Seizure Disorders

Showing all 18 trials

Research Network

Activity Timeline